Indegene, a digital-first life sciences commercialization company, announced a new center in Hyderabad to strengthen its global delivery operations and better address growing business needs. As the pharma industry faces increasing pressure to innovate and adapt, this new center will play a key role in helping companies accelerate their
Revenue from operations increased sequentially by 13% to Rs. 891 crores, down 2% year-on-year First half FY25 revenue was broadly flat, in line with our guidance, at Rs. 1,681 crores Syngene International Limited today announced its second quarter and half year financial results. Revenue from
Indegene today announced a strategic collaboration with Microsoft to empower global life sciences companies to scale up the adoption of purpose-built, enterprise-grade Generative AI (GenAI) services, thereby driving faster innovation at scale. Indegene and Microsoft have committed to developing resources in highly specialized and skilled medical
Full-year revenue from operations up 9% to Rs 3,489 Cr, PAT1 up 12% to Rs 519 Cr Fourth quarter revenue from operations declined 8% year-on-year to Rs. 917 Cr, PAT1 increased 6% to Rs. 189 Cr Syngene International Limited today announced its full-year
Small Dose, Big Impact: HAMSYL Junior to Revolutionize Paediatric Cancer Care Paediatric Pegaspargase Breakthrough: Gennova introduces HAMSYL- Junior, the India’s first-ever 1500 IU paediatric pack size reshaping paediatric oncology care. Tailored for India's Young Warriors: Addressing wastage concerns and vial sharing, HAMSYL Junior, with a
Thermo Fisher Scientific, the world leader in serving science, announces the appointment of Srinath Venkatesh as Managing Director, India and South Asia, for the company. Srinath Venkatesh steps into this pivotal role with a vision to advance Thermo Fisher's growth and operations in India, while enhancing
ENDPOINTS-11 BIOPHARMA’S MOST PROMISING STARTUPS 2023’ INDIA – At the Endpoints News Awards in Boston, USA, Immuneel Therapeutics, India’s leading clinical-stage cell and gene therapy startup, was named and awarded amongst 'Endpoint-11 Biopharma’s Most Promising Startups 2023'. The event annually honours the top 11 global biopharma
Freudenberg Medical launches HelixFlex™ TPE Tubing Indian pharma market Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, components and tubing, has launched HelixFlex™ , a high purity thermoplastic elastomer TPE tubing designed for use in biopharmaceutical fluid transfer applications. This is an expanded product
New brand identity reflects evolution of independent global healthcare network’s capabilities from traditional public relations to integrated media & marketing solutions across more than a dozen disciplines The world’s largest and most robust network of independent healthcare agencies, GLOBALHealthPR, today announced its rebranding to Global
From Microsoft & Medtronic to WHO and Johnson & Johnson, Asia’s biggest biotechnology conference announces a diverse range of experts from technology and healthcare industries Conference to host about 50 speakers, participating across in 7 panels, 2 keynote addresses, a CEO Conclave and a
